1-3
2026
影响因子区间
—
平台估算
29%
2025
中国作者发文占比
—
收费
期刊简介:Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.
【译文】癌症研究是基础和临床肿瘤学领域最受尊敬和认可的期刊之一。它旨在为医生提供关于癌症领域当前进展的全面资源,以及为有效决策所需的广泛可靠信息背景。除了展示具有根本意义的原创论文外,它还发表评论、论文、争议专题报告、新技术及其在特定实验室问题中的应用考虑、公共问题讨论、关于主要主题的迷你系列、新药和疗法,以及创新的编辑信件部分。该期刊的一个独特特点是它的部门化编辑部分,涵盖超过30个主题类别,覆盖肿瘤学领域的广泛专业领域。由领先的医生和研究科学家编辑,这些部分使癌症研究成为寻求理解整个领域有时令人不知所措的大量信息的临床医生的主要资源。除了同行评审的临床研究外,该期刊还特色转化研究,架起实验室和临床之间的桥梁。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |